FSA Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$57K Sell
599
-100
-14% -$9.19K 0.02% 147
2025
Q2
$60.9K Sell
699
-256
-27% -$21.7K 0.02% 134
2025
Q1
$85.8K Buy
955
+152
+19% +$13.6K 0.04% 96
2024
Q4
$64.2K Hold
803
0.03% 127
2024
Q3
$72.3K Buy
+803
New +$67.6K 0.03% 122
2024
Q1
$70K Hold
803
0.03% 115
2023
Q4
$66K Buy
+803
New +$61.2K 0.03% 112
2021
Q1
Sell
-200
Closed -$23K 158
2020
Q4
$23K Buy
+200
New +$22K 0.01% 192
2020
Q3
Sell
-200
Closed -$18K 224
2020
Q2
$18K Hold
200
0.01% 205
2020
Q1
$18K Hold
200
0.02% 191
2019
Q4
$23K Buy
+200
New +$21.9K 0.02% 215

Other funds holding MDT

FSA Wealth Management's MDT Position: Q3 2025 in Review

FSA Wealth Management reduced its Medtronic (MDT) stake by 14% in Q3 2025, selling an estimated $9.19K and leaving 599 shares worth $57K. The position accounts for 0.02% of the portfolio, ranked #147.

FSA Wealth Management first reported a position in MDT in Q4 2019 and has held it in 11 quarters since. The position peaked at $85.8K in Q1 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • FSA Wealth Management held 599 shares of Medtronic worth $57K as of Q3 2025.
  • FSA Wealth Management sold 100 Medtronic shares in Q3 2025, an estimated $9.19K.
  • Medtronic made up 0.02% of FSA Wealth Management's portfolio in Q3 2025, its #147 holding.
  • FSA Wealth Management first reported a position in Medtronic in Q4 2019 and has held it in 11 quarters since.
  • FSA Wealth Management's Medtronic position peaked at $85.8K in Q1 2025.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.